OLUDAMILOLA ABIDEMI OLAJIDE M.D.
Prescription History 1699730721
Internal Medicine - Hematology & Oncology in Raleigh, NC
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for OLUDAMILOLA ABIDEMI OLAJIDE M.D., an active Hematology & Oncology specialist practicing in Raleigh, NC. Our medical registry currently tracks 21 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 924 documented patient claims. Among these therapy options, the most frequently utilized medication is Tamoxifen Citrate, which accounts for 255 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other NC PrescribersVs. NC Avg |
|---|---|---|---|
| Tamoxifen Citrate | 255 | $28.96▼ below NC avg | ▲ More than typical |
About Tamoxifen Citrate: Tamoxifen is used to treat breast cancer. Show more ▾ It is also used to reduce the chances of breast cancer in high-risk patients. This medication can block the growth of breast cancer. It works by interfering with the effects of estrogen in the breast tissue. One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. In 2023, this provider wrote 255 Medicare prescriptions for Tamoxifen Citrate, about 6.4 times the volume of the typical North Carolina prescriber of this medication (40). Medicare paid an average of $28.96 per fill, versus $31.77 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 571.5 30-Day Fills standardized to 30-day supplies 17,130 Days of Medication total across all patients in 2023 | |||
| Anastrozole | 155 | $23.97▼ below NC avg | ▲ More than typical |
About Anastrozole: Anastrozole is used to treat breast cancer in women after menopause. Show more ▾ Some breast cancers are made to grow faster by a natural hormone called estrogen. Anastrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor. It is used in the treatment of ESTROGEN NUCLEAR RECEPTOR-positive breast cancer in postmenopausal women. In 2023, this provider wrote 155 Medicare prescriptions for Anastrozole, about 2.5 times the volume of the typical North Carolina prescriber of this medication (63). Medicare paid an average of $23.97 per fill, versus $24.07 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 388.5 30-Day Fills standardized to 30-day supplies 11,636 Days of Medication total across all patients in 2023 | |||
| Letrozole | 122 | $23.24▼ below NC avg | ▲ More than typical |
About Letrozole: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Letrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women. In 2023, this provider wrote 122 Medicare prescriptions for Letrozole, about 2.1 times the volume of the typical North Carolina prescriber of this medication (59). Medicare paid an average of $23.24 per fill, versus $26.12 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 254.5 30-Day Fills standardized to 30-day supplies 7,618 Days of Medication total across all patients in 2023 | |||
| Prochlorperazine Maleate | 43 | $15.96▼ below NC avg | ▲ More than typical |
About Prochlorperazine Maleate: This medication is used to treat severe nausea and vomiting from certain causes (for example, after surgery or cancer treatment). Show more ▾ Prochlorperazine belongs to a class of drugs known as phenothiazines. This medication is not recommended for use in children younger than 2 years or in children going through surgery. A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. (From Martindale, The Extra Pharmacopoeia, 30th ed, p612) In 2023, this provider wrote 43 Medicare prescriptions for Prochlorperazine Maleate, about 1.4 times the volume of the typical North Carolina prescriber of this medication (31). Medicare paid an average of $15.96 per fill, versus $16.15 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 43 30-Day Fills standardized to 30-day supplies 366 Days of Medication total across all patients in 2023 | |||
| ValacyclovirValacyclovir Hcl | 35 | $40.48▼ below NC avg | ▲ More than typical |
About Valacyclovir: Valacyclovir is used to treat infections caused by certain types of viruses. Show more ▾ In children, it is used to treat cold sores around the mouth (caused by herpes simplex) and chickenpox (caused by varicella zoster). In adults, it is used to treat shingles (caused by herpes zoster) and cold sores around the mouth. Valacyclovir is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, this medication is used to reduce the number of future episodes. Valacyclovir is an antiviral drug. It stops the growth of certain viruses. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Valacyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. A prodrug of acyclovir that is used in the treatment of HERPES ZOSTER and HERPES SIMPLEX VIRUS INFECTION of the skin and mucous membranes, including GENITAL HERPES. In 2023, this provider wrote 35 Medicare prescriptions for Valacyclovir, about 1.6 times the volume of the typical North Carolina prescriber of this medication (22). Medicare paid an average of $40.48 per fill, versus $52.18 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 55 30-Day Fills standardized to 30-day supplies 1,592 Days of Medication total across all patients in 2023 | |||
| Hydroxyurea | 35 | $39.15 | ≈ Typical |
About Hydroxyurea: This medication is used by people with sickle cell anemia to reduce the number of painful crises caused by the disease and to reduce the need for blood transfusions. Show more ▾ Some brands are also used to treat certain types of cancer (such as chronic myelogenous leukemia, squamous cell carcinomas). An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. In 2023, this provider wrote 35 Medicare prescriptions for Hydroxyurea, about the same volume as the typical North Carolina prescriber of this medication (32). Medicare paid an average of $39.15 per fill, versus $35.02 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 96.8 30-Day Fills standardized to 30-day supplies 2,904 Days of Medication total across all patients in 2023 | |||
| IbrancePalbociclib | 34 | $16,511.17 | ▲ More than typical |
About Ibrance: Palbociclib is used to treat a certain type of breast cancer. Show more ▾ It works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 34 Medicare prescriptions for Ibrance, about 1.4 times the volume of the typical North Carolina prescriber of this medication (24). Medicare paid an average of $16,511.17 per fill, versus $14,434.52 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 34 30-Day Fills standardized to 30-day supplies 952 Days of Medication total across all patients in 2023 | |||
| Exemestane | 29 | $243.91 | ≈ Typical |
About Exemestane: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Exemestane is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Exemestane decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. Exemestane is usually not used in women of childbearing age. In 2023, this provider wrote 29 Medicare prescriptions for Exemestane, about 1.2 times the volume of the typical North Carolina prescriber of this medication (25). Medicare paid an average of $243.91 per fill, versus $232.09 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 76 30-Day Fills standardized to 30-day supplies 2,264 Days of Medication total across all patients in 2023 | |||
| RevlimidLenalidomide | 27 | $23,207.57 | ▼ Less than typical |
About Revlimid: Lenalidomide is used to treat various types of cancers. Show more ▾ It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. In 2023, this provider wrote 27 Medicare prescriptions for Revlimid, about half the volume of the typical North Carolina prescriber of this medication (50). Medicare paid an average of $23,207.57 per fill, versus $18,335.64 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 27 30-Day Fills standardized to 30-day supplies 756 Days of Medication total across all patients in 2023 | |||
| Gabapentin | 25 | $18.38▼ below NC avg | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2023, this provider wrote 25 Medicare prescriptions for Gabapentin, about a quarter of the volume of the typical North Carolina prescriber of this medication (101). Medicare paid an average of $18.38 per fill, versus $21.91 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 56.3 30-Day Fills standardized to 30-day supplies 1,690 Days of Medication total across all patients in 2023 | |||
| VerzenioAbemaciclib | 23 | $15,708.01 | ▲ More than typical |
About Verzenio: This medication is used to treat certain types of breast cancer. Show more ▾ Abemaciclib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors. In 2023, this provider wrote 23 Medicare prescriptions for Verzenio, about 1.4 times the volume of the typical North Carolina prescriber of this medication (17). Medicare paid an average of $15,708.01 per fill, versus $14,339.94 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 23 30-Day Fills standardized to 30-day supplies 644 Days of Medication total across all patients in 2023 | |||
| Oxycodone Hcl | 20 | $5.97▼ below NC avg | ▼ Less than typical |
About Oxycodone Hcl: This medication is used to help relieve moderate to severe pain. Show more ▾ Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. A semisynthetic derivative of CODEINE. In 2023, this provider wrote 20 Medicare prescriptions for Oxycodone Hcl, about a third of the volume of the typical North Carolina prescriber of this medication (69). Medicare paid an average of $5.97 per fill, versus $26.92 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 20 30-Day Fills standardized to 30-day supplies 239 Days of Medication total across all patients in 2023 | |||
| XareltoRivaroxaban | 16 | $1,129.76 | ▼ Less than typical |
About Xarelto: Rivaroxaban is used to prevent blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip or knee replacement surgery. Show more ▾ It is also used to prevent blood clots from forming in high-risk patients with limited mobility during their hospital stay and after discharge. In addition, rivaroxaban is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and to prevent the blood clots from forming again. Rivaroxaban may be used in children to prevent blood clots from forming after a certain heart surgery (Fontan procedure). Rivaroxaban is an anticoagulant that works by blocking certain clotting proteins in your blood. A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME. In 2023, this provider wrote 16 Medicare prescriptions for Xarelto, about a third of the volume of the typical North Carolina prescriber of this medication (43). Medicare paid an average of $1,129.76 per fill, versus $850.84 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 31.7 30-Day Fills standardized to 30-day supplies 950 Days of Medication total across all patients in 2023 | |||
| CalquenceAcalabrutinib Maleate | 16 | $6,081.38▼ below NC avg | ≈ Typical |
About Calquence: This medication is used to treat certain types of cancer (such as mantle cell lymphoma, small lymphocytic lymphoma - SLL, chronic lymphocytic leukemia - CLL). Show more ▾ Acalabrutinib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors. In 2023, this provider wrote 16 Medicare prescriptions for Calquence, about the same volume as the typical North Carolina prescriber of this medication (14). Medicare paid an average of $6,081.38 per fill, versus $15,907.43 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 16 30-Day Fills standardized to 30-day supplies 449 Days of Medication total across all patients in 2023 | |||
| Imatinib Mesylate | 16 | $328.23▼ below NC avg | ▼ Less than typical |
About Imatinib Mesylate: This medication is used to treat certain types of cancer (such as acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases). Show more ▾ It works by slowing or stopping the growth of cancer cells. Imatinib may also be used to treat certain immune system disorders (such as aggressive systemic mastocytosis, hypereosinophilic syndrome). A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors. In 2023, this provider wrote 16 Medicare prescriptions for Imatinib Mesylate, about 73% of the volume of the typical North Carolina prescriber of this medication (22). Medicare paid an average of $328.23 per fill, versus $1,496.07 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 18 30-Day Fills standardized to 30-day supplies 540 Days of Medication total across all patients in 2023 | |||
| Lenalidomide | 15 | $17,683.65 | ≈ Typical |
About Lenalidomide: Lenalidomide is used to treat various types of cancers. Show more ▾ It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. In 2023, this provider wrote 15 Medicare prescriptions for Lenalidomide, about 83% of the volume of the typical North Carolina prescriber of this medication (18). Medicare paid an average of $17,683.65 per fill, versus $14,557.58 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 15 30-Day Fills standardized to 30-day supplies 420 Days of Medication total across all patients in 2023 | |||
| Colestipol Hcl | 14 | $118.81 | ▼ Less than typical |
About Colestipol Hcl: Colestipol is used along with a proper diet to lower cholesterol in the blood. Show more ▾ Lowering cholesterol helps decrease the risk for strokes and heart attacks. In addition to a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. This medication is known as a bile acid-binding resin. It works by removing bile acid from the body. In people with high cholesterol, this causes the liver to make more bile acid by using cholesterol in the blood. This helps to lower the cholesterol levels. Highly crosslinked and insoluble basic anion exchange resin used as anticholesteremic. It may also may reduce triglyceride levels. In 2023, this provider wrote 14 Medicare prescriptions for Colestipol Hcl, about half the volume of the typical North Carolina prescriber of this medication (25). Medicare paid an average of $118.81 per fill, versus $100.89 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 34 30-Day Fills standardized to 30-day supplies 1,010 Days of Medication total across all patients in 2023 | |||
| KisqaliRibociclib Succinate | 11 | $10,497.05▼ below NC avg | ▼ Less than typical |
About Kisqali: Ribociclib is used to treat breast cancer. Show more ▾ It works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 11 Medicare prescriptions for Kisqali, about 73% of the volume of the typical North Carolina prescriber of this medication (15). Medicare paid an average of $10,497.05 per fill, versus $12,683.25 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 11 30-Day Fills standardized to 30-day supplies 308 Days of Medication total across all patients in 2023 | |||
| ImbruvicaIbrutinib | 11 | $5,665.07▼ below NC avg | ▼ Less than typical |
About Imbruvica: This medication is used to treat certain cancers (such as mantle cell or marginal zone lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom's macroglobulinemia). Show more ▾ Ibrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. Ibrutinib is also used to treat a certain problem that may occur after a stem cell transplant (chronic graft versus host disease). It works by weakening your body's defense system (immune system). In 2023, this provider wrote 11 Medicare prescriptions for Imbruvica, about a third of the volume of the typical North Carolina prescriber of this medication (31). Medicare paid an average of $5,665.07 per fill, versus $14,540.78 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 11 30-Day Fills standardized to 30-day supplies 308 Days of Medication total across all patients in 2023 | |||
| Dexamethasone | 11 | $10.97▼ below NC avg | ▼ Less than typical |
About Dexamethasone: Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. Show more ▾ It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. An anti-inflammatory 9-fluoro-glucocorticoid. In 2023, this provider wrote 11 Medicare prescriptions for Dexamethasone, about a third of the volume of the typical North Carolina prescriber of this medication (28). Medicare paid an average of $10.97 per fill, versus $16.89 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 11 30-Day Fills standardized to 30-day supplies 133 Days of Medication total across all patients in 2023 | |||
| JakafiRuxolitinib Phosphate | 11 | $9,113.70▼ below NC avg | ▼ Less than typical |
About Jakafi: This medication is used to treat certain bone marrow disorders (myelofibrosis, polycythemia vera). Show more ▾ It works by blocking your body from producing substances called growth factors. Growth factors cause cells to grow and divide, and cause the blood cell and spleen problems found in these disorders. Ruxolitinib belongs to a class of drugs known as kinase inhibitors. Though not a cure for these disorders, ruxolitinib may help with some of the symptoms, including abdominal discomfort, pain under left ribs, early feelings of fullness from meals, night sweats, itching, and bone/muscle pain. Ruxolitinib is also used to treat a certain problem that may occur after certain stem cell or bone marrow transplants (graft versus host disease). It works by weakening your body's defense system (immune system). In 2023, this provider wrote 11 Medicare prescriptions for Jakafi, about a third of the volume of the typical North Carolina prescriber of this medication (27). Medicare paid an average of $9,113.70 per fill, versus $15,844.64 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for OLUDAMILOLA ABIDEMI OLAJIDE M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hematology & Oncology prescribing approach at this Raleigh, NC practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among NC prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
